Replies to post #217624 on Biotech Values

[Biowatch]

I learned a lot from IMCL

If I sold everything the day the chief scientific officer sold $300 million in stock, I would have made the most money.

If I sold when the CEO said they didn't have a "denominator" for the clinical trial data, I would have made more money.

If I sold when I saw the CEO's daughter and others selling, I would have made more, but I held on.

I still made money because I had faith in the drug, traded the stock, and bought early, but boy did I miss some big red flags.